2NCCLS.Clinical and Laboratory Standards lnstitute(CLSl).Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals [J]. approved standard-Third Edition. 2006(28): 56-58.
8Woodford N, Tieruo P M Jr, Young K, et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem- hydrolyxing class A β-lactamase, KPC-3, in a New York medical center [J]. Antimicrob Agents Chemother,2004,48 (12):4793-4799.
9Masuda N, Sakagawa E, Ohya S. Outermembrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa [J]. Antimicrob Agents Chemother, 1995,39(3):645-649
10Ribera A, Jurado A, Ruiz J, et al. In vitro activity of clinafloxacin in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and absence of reserpine [J]. Diagn Microb Infect Dis,2002,42(2) : 123-128.
9Munoz-Price LS, Poirel L, Bonomo RA, et al.Clinical epi- demiology of the global expansion of Klebsiella pneu- moniae carbapenemases[J]. Lancet Infect Dis, 2013, 13 (9) :785.
10Wei ZQ, Du XX, Yu YS, et al.Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China[J]. Antimi- crob Agents Chemother, 2007,51 (2) : 763.
